Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.7050
-0.0097 (-1.36%)
Aug 14, 2025, 2:23 PM - Market open
Xilio Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 89.07 | 55.29 | 44.7 | 120.39 | 198.05 | 19.24 | Upgrade
|
| Cash & Short-Term Investments | 89.07 | 55.29 | 44.7 | 120.39 | 198.05 | 19.24 | Upgrade
|
| Cash Growth | 162.13% | 23.68% | -62.87% | -39.22% | 929.49% | -60.61% | Upgrade
|
| Other Receivables | 2 | 2 | - | - | - | - | Upgrade
|
| Receivables | 2 | 2 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 2.13 | 2.94 | 3.42 | 4.11 | 4.46 | 1.35 | Upgrade
|
| Total Current Assets | 93.2 | 60.23 | 48.13 | 124.5 | 202.52 | 20.59 | Upgrade
|
| Property, Plant & Equipment | 8.73 | 9.06 | 11.2 | 13.06 | 13.9 | 14.06 | Upgrade
|
| Other Long-Term Assets | 1.79 | 1.78 | 1.6 | 1.61 | 1.64 | 1.66 | Upgrade
|
| Total Assets | 103.72 | 71.08 | 60.93 | 139.17 | 218.06 | 36.32 | Upgrade
|
| Accounts Payable | 2.28 | 2.57 | 1.05 | 3.13 | 3.14 | 5.44 | Upgrade
|
| Accrued Expenses | 3.88 | 9.98 | 10.5 | 10.33 | 8.75 | 13.73 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 3.32 | 6.67 | - | 2.33 | Upgrade
|
| Current Portion of Leases | 1.23 | 1.19 | 1.1 | 1 | 0.88 | 0.65 | Upgrade
|
| Current Unearned Revenue | 40.25 | 13.52 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 47.64 | 27.26 | 15.96 | 21.12 | 12.78 | 22.16 | Upgrade
|
| Long-Term Debt | - | - | - | 3.17 | 9.63 | 7.81 | Upgrade
|
| Long-Term Leases | 6.64 | 6.95 | 8.14 | 9.23 | 10.23 | 11.1 | Upgrade
|
| Long-Term Unearned Revenue | 38.74 | 19.26 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.54 | Upgrade
|
| Total Liabilities | 93.02 | 53.48 | 24.1 | 33.52 | 32.63 | 41.6 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | - | Upgrade
|
| Additional Paid-In Capital | 407.71 | 401.35 | 362.34 | 354.75 | 346.31 | 1.8 | Upgrade
|
| Retained Earnings | -397.02 | -383.75 | -325.51 | -249.11 | -160.89 | -85.09 | Upgrade
|
| Total Common Equity | 10.7 | 17.6 | 36.83 | 105.65 | 185.43 | -83.29 | Upgrade
|
| Shareholders' Equity | 10.7 | 17.6 | 36.83 | 105.65 | 185.43 | -5.29 | Upgrade
|
| Total Liabilities & Equity | 103.72 | 71.08 | 60.93 | 139.17 | 218.06 | 36.32 | Upgrade
|
| Total Debt | 7.86 | 8.14 | 12.55 | 20.07 | 20.74 | 21.89 | Upgrade
|
| Net Cash (Debt) | 81.21 | 47.15 | 32.15 | 100.32 | 177.32 | -2.65 | Upgrade
|
| Net Cash Growth | 224.73% | 46.64% | -67.95% | -43.42% | - | - | Upgrade
|
| Net Cash Per Share | 1.25 | 0.88 | 1.17 | 3.66 | 31.63 | -5.06 | Upgrade
|
| Filing Date Shares Outstanding | 51.78 | 51.77 | 34.47 | 27.43 | 27.36 | 0.81 | Upgrade
|
| Total Common Shares Outstanding | 51.78 | 45.76 | 27.61 | 27.43 | 27.36 | 0.81 | Upgrade
|
| Working Capital | 45.56 | 32.97 | 32.17 | 103.38 | 189.74 | -1.57 | Upgrade
|
| Book Value Per Share | 0.21 | 0.38 | 1.33 | 3.85 | 6.78 | -103.39 | Upgrade
|
| Tangible Book Value | 10.7 | 17.6 | 36.83 | 105.65 | 185.43 | -83.29 | Upgrade
|
| Tangible Book Value Per Share | 0.21 | 0.38 | 1.33 | 3.85 | 6.78 | -103.39 | Upgrade
|
| Machinery | 6.91 | 6.78 | 6.68 | 6.45 | 4.67 | 3.64 | Upgrade
|
| Construction In Progress | - | - | - | 0.1 | 0.54 | - | Upgrade
|
| Leasehold Improvements | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.09 | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.